Contrast-enhanced harmonic endoscopic ultrasonography for predicting the efficacy of first-line gemcitabine and nab-paclitaxel chemotherapy in pancreatic cancer

The purpose of this study was to assess prognosis with different intratumoral vascularity on contrast-enhanced endoscopic harmonic ultrasonography (CH-EUS) in pancreatic cancer patients receiving chemotherapy. Patients with unresectable pancreatic cancer who underwent CH-EUS before first-line gemcit...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 2022-05, Vol.22 (4), p.525-533
Hauptverfasser:	Emori, Tomoya, Ashida, Reiko, Tamura, Takashi, Kawaji, Yuki, Hatamaru, Keiichi, Itonaga, Masahiro, Yamashita, Yasunobu, Shimokawa, Toshio, Higashino, Nobuyuki, Ikoma, Akira, Sonomura, Tetsuo, Kawai, Manabu, Kitano, Masayuki
Format:	Artikel
Sprache:	eng
Schlagworte:	Albumins - therapeutic use Antineoplastic Combined Chemotherapy Protocols - therapeutic use Cancer therapies Cardiovascular disease Chemotherapy Computed tomography Contrast agents Contrast harmonic endoscopic ultrasound Deoxycytidine - analogs & derivatives Endoscopy Endosonography - methods Gemcitabine Humans Medical prognosis Metastasis Nab-paclitaxel Paclitaxel Pancreatic cancer Pancreatic Neoplasms Pancreatic Neoplasms - diagnostic imaging Pancreatic Neoplasms - drug therapy Pancreatic Neoplasms - etiology Patients Predicting efficacy of chemotherapy Survival Tumors Ultrasonic imaging Veins & arteries
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!